Koshariya Mahim, Shukla Shikha, Ansari Fahad, Khare Vidhu
Department of General Surgery, Gandhi Medical College and Associated Hamidia Hospital, Bhopal, IND.
Cureus. 2022 Jul 25;14(7):e27237. doi: 10.7759/cureus.27237. eCollection 2022 Jul.
The incidence of breast carcinoma in young women is on the rise, particularly in developing Asian countries like India. Owing to a unique presentation in terms of genetic background, clinical features, and histological characteristics, the prognosis becomes challenging, which therefore entails a detailed study for better understanding and management of the disease. This study aimed to establish the role of clinical and pathological parameters in breast cancer disease in young women.
This was a prospective comparative study conducted at the Department of Surgery, Hamidia Hospital, Bhopal, India, which spanned a total duration of one year between November 2018 and October 2019, and included a total of 98 consecutive in-house breast carcinoma patients. The patients were categorized into two groups based on age, i.e., the young age group (age < 40 years) and the old age group (age ≥ 40 years).
Of the patients, 37 fell in the young age group and 61 in the old age group. There was a significant association between positive family history of breast carcinoma and young age (p = 0.01). Estrogen and progesterone receptor positivity was found to be associated more commonly with old age group patients. The proportion of patients with human epidermal growth factor receptor 2 (HER2)/neu over-expression was higher among the young age group. Triple negativity was more frequently observed amongst young age group patients.
Hormone receptor analysis should be an absolute part of the initial work-up of breast carcinoma. Raising awareness among women in society should be of paramount importance. Family history is crucial, particularly in young women, and should not be dismissed. With timely presentation and effective diagnosis, a safer state with a relatively better prognosis can be achieved.
年轻女性乳腺癌的发病率正在上升,尤其是在印度等亚洲发展中国家。由于在基因背景、临床特征和组织学特征方面呈现出独特性,其预后颇具挑战性,因此需要进行详细研究以更好地了解和管理该疾病。本研究旨在确定临床和病理参数在年轻女性乳腺癌疾病中的作用。
这是一项前瞻性比较研究,在印度博帕尔哈米迪亚医院外科进行,研究时间跨度为2018年11月至2019年10月,共一年,纳入了98例连续的住院乳腺癌患者。根据年龄将患者分为两组,即年轻组(年龄<40岁)和老年组(年龄≥40岁)。
患者中,37例属于年轻组,61例属于老年组。乳腺癌家族史阳性与年轻年龄之间存在显著关联(p = 0.01)。发现雌激素和孕激素受体阳性在老年组患者中更为常见。年轻组中人表皮生长因子受体2(HER2)/neu过表达患者的比例更高。年轻组患者中三阴性更为常见。
激素受体分析应成为乳腺癌初始检查的绝对组成部分。提高社会女性的意识至关重要。家族史至关重要,尤其是在年轻女性中,不应被忽视。通过及时就诊和有效诊断,可以实现预后相对较好的更安全状态。